Oncimmune Holdings PLC Successful £5.0m placing
Oncimmune Holdings PLC (LON:ONC), has today announced that, following the announcement made on 26 September 2017 entitled “Proposed Placing to raise up to £5.3 million”, the Company has raised a
?>
Oncimmune Holdings PLC (LON:ONC), has today announced that, following the announcement made on 26 September 2017 entitled “Proposed Placing to raise up to £5.3 million”, the Company has raised a
Oncimmune Holdings PLC (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT®platform technology, yesterday announced a proposed placing to raise up to £5.3 million, (£5.0 million net
Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, today announced it has signed three new exclusive distribution agreements for its EarlyCDT®-
Oncimmune Holdings PLC (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, today announced that data relating to the development of its EarlyCDT®-Liver panel was
Oncimmune Holdings PLC (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, today provides an update on the business ahead of the announcement of full year
Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, and Scancell Holdings plc, (‘Scancell’) the developer of novel immunotherapies for the treatment
In order to raise awareness around a new early-detection lung cancer screening, the American Lung Association launched a new campaign. Using video, print ads, a quiz, and other tactics, the
Lung cancer continues to be one of the most common cancers worldwide, claiming more lives yearly than breast, colon, and prostate cancers combined. It is estimated that lung cancer accounts
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according
But 3.9 million youth were still using tobacco products in 2016. The number of middle and high school students who say they are current tobacco users – defined as having